PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Sinai Center for Thrombosis Research and Drug Development, Sinai Hospital of Baltimore, Lifebridge Health, Baltimore, MD, 21215, USA.\', \'Sinai Center for Thrombosis Research and Drug Development, Sinai Hospital of Baltimore, Lifebridge Health, Baltimore, MD, 21215, USA. pgurbel@lifebridgehealth.org.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1007/s11239-022-02631-7
?:hasPublicationType
?:journal
  • Journal of thrombosis and thrombolysis
is ?:pmid of
?:pmid
?:pmid
  • 35041121
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.991
?:rankingScore_hIndex
  • 57
is ?:relation_isRelatedTo_publication of
?:title
  • Metformin use in patients hospitalized with COVID-19: lower inflammation, oxidative stress, and thrombotic risk markers and better clinical outcomes.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35041121>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35041121>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all